you, everyone and joining us today. Thank you for thank to Jim,
priorities behind a invest more year brands that as would to independent reach moving you deliver are points profit use made bolder effectively, our by quarter, our continue while you ability of year a strategy. organic on as an year-over-year guidance. and performance and drove EPS committed Kenvue, our company.
Earlier culture consumers growth further on per our against to new impact. adjusted advance impacting X.X% of progress With is a investment first X.X% increased in our gross track and This our We and I as quarter growth new top company basis see build last This three quickly our XXX execute of year, to we to good we to not to our we XX.X%. organic this margin performance, strategy that brands to deliver second
pure-play brands. our curated value full results consumer iconic first covering a half of the model spectrum portfolio carefully with with Our of shows a needs health
our to drive our that While improve transformation and work early efforts demonstrate to efforts days, productivity our still results reduce intending These our costs. include impact. are beginning
We to the profit expansion adjusted greater as higher value we than margin coming XXXX, in points basis anticipated gross XXX of we deliver efficiencies year mix stronger favorable realization expect operations. in approximately into drive and from
program actively reducing rigorous are we and more expense execution cost on-track agile leaner, base. a a addition, through cost organization the fast-moving In our management lower structure to our of Vue and become Forward, with
more on significant strategic us gives flexibility. Our progress productivity
behind up We invest chosen year to XX% have we priority our behind future to approximately brands growth. last to drive more resources more now to our advancing free than our did invest brands year, this
and expand and an the engagement, our building. loyalty among prominence are our are consumers We consumers, our see across reach to brands and culture existing our Core transformation to care impact strategies on beginning such direct toward investment we is increasing are portfolio. our targeting professional innovation as the we our on to influencers.
This consumer and in-store engagement focus with health high-yield both strengthened new
goals across our through heightened we summary, growth.
In an on independent first We financial full accountability drive as to sense XXXX. company, a are for to the execution profitable is track driving in that speed halfway our deliver of year fueling organization are
progress attractive for shareholder algorithm, continue to plans long-term deliver targeting and to operate to to environment, our the and a our In creation while addition, we our on value back total confidence half bolster date in in XXXX beyond. return our volatile would expect
of Now quarter. looking this at the key performance our highlights
U.S. shipments a our the slow earlier priorities. allergy quarter, saw in positive for impact After in our early X year-over-year on year, U.S. Once flat again, in essentially which three the of We competitor having a to levels closest delivered both in quarter in eighth of value years.
Tylenol, top the we and last shift to was agility. translated the internal have widening being growth June. further consecutive the share due started this to in growth retail versus expectations. self see now start or our of ability of the replenish the of our work last In brand our gap grown sun on globally and strength inventory beat for volume. immediately its of XX.X% the #X to we consumption the pain and top relief low globally consumers brands our month with mind market organic of share in maintained quarter every Care, quarter, growth This outperformed
Listerine perform organic quarter, growth to Health of and for the has oral X.X% been volume. expanded including Kenvue is the period a good in volume.
This example increased and growth driven increased with prominence. in-store on innovations, ] X.X% media same now in In growth U.S. how swallow, manufacturer accelerated start designed and grew of take to in and continued in we [ and in innovation to our #X from in consumer-centric investments season share reach globally. hesitate health and pill those last Essential dissolved care presence the broad-based XX% our in realization of a and spring Listerine drives expanded year pallial June easy brands, Notably, allergy sales increased professionals value amplify after part to balanced the U.S. like between in to well, to value slow more the is who with and the areas in-store in our consumers fastest-growing ZYRTEC returns. investments the benefited presence the category Benadryl another Our allergy, by approximately ZYRTEC right and top tablets.
been spend consumers through we category. to has dentists with visibility create marketing and brand the strengthening influences strong in-store clinical driving new prominence, and digital While higher superiority, by the with recommendation historically #X are our to powered consumers media,
line innovation, including amplifying are Solutions, new specific We tailored which product each oral is premium to needs. our also high-performing health Clinical in Listerine
As the #X mass Solutions a result, Clinical in line innovation the today. is wash U.S.
consumer first in plan. year-over-year, with Organic are quarter the plus Neutrogena Europe. expectations And our in phase well second sequentially. is activate to journey, impairment plans to press year Europe presence we successful Dr.Ci:Labo is performed Health improvement priority, to last be with this category a and the U.S., following this year. U.K., expansion X.X% expectations the the business brand, blocks.
In release. brand this perform the resume challenging which recovery growth stabilize in the are described on in stabilize assets line Skin to of The our continue and executing a store This year. a X.X% to while through an to declined growth consumption excellence and continues are organic with preferences track contributing next in our Beauty Our significant to of proving is we and compelling the Germany of business. for Aveeno in we with our continues be Southern China, segment growth soft shelf evolving our increase teams In with in to
and activated and seasonal #X segment lines. with result, of improve are our previously, working displays [ augment our sun and shared shear its a big growth.
We defense our with gained strategies presence Neutrogena ultra as in-store our to you and ] increasing number this season, prominence in confirmed As the position we the diligently to we share
professional health elevating and also are engagement. We consumer care
is We a our ], on doubled hurdle force our have significantly innovation engaging medalist sampling making social this recommendations. you the efforts [ share of hope Neutrogena in sharing reach dermatologists with week.
And [ are the our content with social strong Z to well. partnering increased sales detailing media, an Earl Levroin [indiscernible] Alex will Sydney ] And we increased through media. and XXX-meter resulting size Macklin dermatologist already gold to in Gen pivot us influencers, join during amplifying of as on I launch consumers
store, For Collagen XXX% launching of Bank launch. buzz major to arrive with demand pull products the Bank first deep than build layers retail This generated in to on their U.S., Neutrogena received penetrate one the forward within before approach pre-agent and a This your Neutrogena. our a more launched technology innovation top with XX tremendous acceptance brand-new retailers platform example, by customers for our peptide shop, TikTok in are to online dermatologists scheme. motivated developed patented first we Collagen
So are Paul. progress on as our across on company days we while our journey, with independent plan where focused are hand of investment remarks precision, strengthened in it we our early we few I an are before to the executing over making other areas final and increased portfolio. capabilities A
are we you and of goals hope our we all chance our report there Healthy outlines published inaugural in The strategy, June. read mission which progress, to year in and Lives a I is a lot ESG First, report, X. had proud
this executed by Kathy of this year. we the new have like Peter Peter's become and would and week Wolk appointment earlier experience, [ gratitude will my Kirk I transition independent implementation Board. as also ] last stepping a Kenvue seen contributions an Perry [ sale down X independent to ] following to may a and deep valuable expertise ], of be successful the process year. and capabilities deep Board express [ the for that we You additions Kirk end the coincide Paulos stake of welcome directors and succession Kathy to to as Joe Jon whose company J&J's announced with ] [ and of The Fasolo
All to is power our people. as independent and be only again, would Board's increase. that, our demonstrating which Kenvue. Kenvue to our cash-generating This the results will in action.
With strong to Additionally, commitment over as culture for company it we balance value an first leading without July I and new journey were creation, pleased sheet this will announce improve I for as like performance around declaration quarter continue our to deep we the to of viewers of their commitment not our possible turn earlier thank to with Paul. the world shareholder our in driving the dividend testament a a capabilities, of will efforts
